Logo image of NEPH

NEPHROS INC (NEPH) Stock Fundamental Analysis

NASDAQ:NEPH - Nasdaq - US6406714005 - Common Stock - Currency: USD

3.87  -0.14 (-3.49%)

Premarket: 3.88 +0.01 (+0.26%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to NEPH. NEPH was compared to 128 industry peers in the Machinery industry. NEPH has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, NEPH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NEPH was profitable.
NEPH had a positive operating cash flow in the past year.
NEPH had negative earnings in 4 of the past 5 years.
NEPH had negative operating cash flow in 4 of the past 5 years.
NEPH Yearly Net Income VS EBIT VS OCF VS FCFNEPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

NEPH's Return On Assets of 6.80% is fine compared to the rest of the industry. NEPH outperforms 65.63% of its industry peers.
NEPH has a Return On Equity (8.62%) which is comparable to the rest of the industry.
NEPH has a Return On Invested Capital (6.26%) which is in line with its industry peers.
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROIC 6.26%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
NEPH Yearly ROA, ROE, ROICNEPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

NEPH's Profit Margin of 5.16% is in line compared to the rest of the industry. NEPH outperforms 48.44% of its industry peers.
NEPH has a worse Operating Margin (4.98%) than 62.50% of its industry peers.
The Gross Margin of NEPH (62.45%) is better than 97.66% of its industry peers.
NEPH's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
NEPH Yearly Profit, Operating, Gross MarginsNEPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NEPH is destroying value.
Compared to 1 year ago, NEPH has about the same amount of shares outstanding.
The number of shares outstanding for NEPH has been increased compared to 5 years ago.
Compared to 1 year ago, NEPH has a worse debt to assets ratio.
NEPH Yearly Shares OutstandingNEPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NEPH Yearly Total Debt VS Total AssetsNEPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

NEPH has an Altman-Z score of -4.90. This is a bad value and indicates that NEPH is not financially healthy and even has some risk of bankruptcy.
NEPH has a Altman-Z score of -4.90. This is amonst the worse of the industry: NEPH underperforms 91.41% of its industry peers.
NEPH has a debt to FCF ratio of 0.05. This is a very positive value and a sign of high solvency as it would only need 0.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.05, NEPH belongs to the top of the industry, outperforming 92.19% of the companies in the same industry.
NEPH has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
NEPH has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. NEPH outperforms 83.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Altman-Z -4.9
ROIC/WACC0.62
WACC10.11%
NEPH Yearly LT Debt VS Equity VS FCFNEPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 5.92 indicates that NEPH has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 5.92, NEPH belongs to the top of the industry, outperforming 94.53% of the companies in the same industry.
NEPH has a Quick Ratio of 4.64. This indicates that NEPH is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NEPH (4.64) is better than 94.53% of its industry peers.
Industry RankSector Rank
Current Ratio 5.92
Quick Ratio 4.64
NEPH Yearly Current Assets VS Current LiabilitesNEPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 150.00% over the past year.
The Revenue has grown by 10.32% in the past year. This is quite good.
NEPH shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.51% yearly.
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
Revenue 1Y (TTM)10.32%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%38.47%

3.2 Future

The Earnings Per Share is expected to grow by 10844260754.01% on average over the next years. This is a very strong growth
Based on estimates for the next years, NEPH will show a quite strong growth in Revenue. The Revenue will grow by 14.70% on average per year.
EPS Next Y587989967349491800%
EPS Next 2Y10844260754.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NEPH Yearly Revenue VS EstimatesNEPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M
NEPH Yearly EPS VS EstimatesNEPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 55.29, the valuation of NEPH can be described as expensive.
Based on the Price/Earnings ratio, NEPH is valued a bit more expensive than the industry average as 69.53% of the companies are valued more cheaply.
NEPH's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.32.
With a Price/Forward Earnings ratio of 94.85, NEPH can be considered very expensive at the moment.
71.09% of the companies in the same industry are cheaper than NEPH, based on the Price/Forward Earnings ratio.
NEPH's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 22.13.
Industry RankSector Rank
PE 55.29
Fwd PE 94.85
NEPH Price Earnings VS Forward Price EarningsNEPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NEPH is valued a bit more expensive than 75.00% of the companies in the same industry.
70.31% of the companies in the same industry are cheaper than NEPH, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 91.77
EV/EBITDA 40.4
NEPH Per share dataNEPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1

4.3 Compensation for Growth

NEPH's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
NEPH's earnings are expected to grow with 10844260754.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0
PEG (5Y)N/A
EPS Next 2Y10844260754.01%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

NEPH does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NEPHROS INC

NASDAQ:NEPH (6/13/2025, 8:26:44 PM)

Premarket: 3.88 +0.01 (+0.26%)

3.87

-0.14 (-3.49%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-06 2025-08-06
Inst Owners44.01%
Inst Owner Change-0.99%
Ins Owners10.74%
Ins Owner Change2.61%
Market Cap41.02M
Analysts82.5
Price Target4.85 (25.32%)
Short Float %0.03%
Short Ratio0.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)688.24%
Min EPS beat(2)296.08%
Max EPS beat(2)1080.39%
EPS beat(4)3
Avg EPS beat(4)369.61%
Min EPS beat(4)-96.08%
Max EPS beat(4)1080.39%
EPS beat(8)6
Avg EPS beat(8)186.58%
EPS beat(12)7
Avg EPS beat(12)103.11%
EPS beat(16)8
Avg EPS beat(16)71.4%
Revenue beat(2)2
Avg Revenue beat(2)18.61%
Min Revenue beat(2)6.29%
Max Revenue beat(2)30.93%
Revenue beat(4)2
Avg Revenue beat(4)4.59%
Min Revenue beat(4)-17.42%
Max Revenue beat(4)30.93%
Revenue beat(8)4
Avg Revenue beat(8)1.96%
Revenue beat(12)5
Avg Revenue beat(12)-0.04%
Revenue beat(16)5
Avg Revenue beat(16)-3.1%
PT rev (1m)5.56%
PT rev (3m)-5%
EPS NQ rev (1m)-300%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)0%
Revenue NY rev (3m)7.44%
Valuation
Industry RankSector Rank
PE 55.29
Fwd PE 94.85
P/S 2.64
P/FCF 91.77
P/OCF 81.72
P/B 4.42
P/tB 5.14
EV/EBITDA 40.4
EPS(TTM)0.07
EY1.81%
EPS(NY)0.04
Fwd EY1.05%
FCF(TTM)0.04
FCFY1.09%
OCF(TTM)0.05
OCFY1.22%
SpS1.46
BVpS0.88
TBVpS0.75
PEG (NY)0
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 6.8%
ROE 8.62%
ROCE 7.52%
ROIC 6.26%
ROICexc 10.39%
ROICexgc 13.16%
OM 4.98%
PM (TTM) 5.16%
GM 62.45%
FCFM 2.88%
ROA(3y)-26.57%
ROA(5y)-25.75%
ROE(3y)-50%
ROE(5y)-44.65%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.79%
GM growth 5Y0.91%
F-Score6
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.05
Debt/EBITDA 0.02
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 772
Cash Conversion 54.86%
Profit Quality 55.81%
Current Ratio 5.92
Quick Ratio 4.64
Altman-Z -4.9
F-Score6
WACC10.11%
ROIC/WACC0.62
Cap/Depr(3y)38.4%
Cap/Depr(5y)49.1%
Cap/Sales(3y)0.77%
Cap/Sales(5y)1.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)150%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%350%
EPS Next Y587989967349491800%
EPS Next 2Y10844260754.01%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)10.32%
Revenue growth 3Y11.49%
Revenue growth 5Y6.51%
Sales Q2Q%38.47%
Revenue Next Year17.25%
Revenue Next 2Y14.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y151.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y135.48%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y143.65%
OCF growth 3YN/A
OCF growth 5YN/A